Ovulation and Follicular Development Associated With Mid Follicular Phase Initiation of Combined Hormonal Contraception

Ovulation Inhibition Clinical Trial

Official title:
Ovulation and Follicular Development Associated With Mid Follicular Phase Initiation of Combined Hormonal Contraception Containing Estradiol Hemihydrate Compared to Ethinyl Estradiol

Status Completed

Clinical Trial Summary

Quick starting combined oral contraception containing estradiol hemihydrate/nomegestrol acetate is effective to inhibit ovulation in healthy reproductive age women and non-inferiority to combined oral contraception containing ethinyl estradiol/gestodene.

Clinical Trial Description

This study is a randomized control, non-inferiority trial which compare the proportion of ovulation between two oral combined pills when delay starting the first tablet at mid-follicular phase of menstrual cycle in 18 - 40 year old, healthy women with prior normal and regular periods. Participations will be undergone trans-vaginal or trans-rectal ultrasonography between day 1 - 3 of menstrual period for evaluation of ovarian follicle/cyst (if present). Only women who have normal looking of ovaries without dominant ovarian follicle will be included in study-protocol. Immediately after trans-vaginal/trans-rectal ultrasound between day 7 - 9 of menstrual period, all participants will be randomly assigned to receive one pack of investigated pills (1.5 mg estradiol hemihydrate/2.5 mg nomegestrol acetate or 20 mcg ethinyl estradiol/75 mcg gestodene) and to take the first tablet under direct observation by research-nurse. Participants will take one consecutive tablet at about the same time each day until complete pack. The next appointments will be every 2 - 3 days to monitor ovarian function by using Hoogland score until ovulation or follicular quiescence will be presented. The last visit will be about 1 week after complete pack to monitor adverse effect and safety through out the protocol. ;

Study Design

Related Conditions & MeSH terms

Ovulation Inhibition

Clinical Trial Details

NCT number	NCT03077555
Study type	Interventional
Source	Mahidol University
Contact
Status	Completed
Phase	Phase 4
Start date	January 21, 2017
Completion date	February 28, 2018

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00567164` - Efficacy and Safety of Two Flexible Extended Regimens of BAY86-5300 (SH T00186D) in Comparison With the Conventional Regimen of YAZ	Phase 3
Active, not recruiting	`NCT02451826` - A Study to Evaluate the Effect of a Contraceptive Vaginal Ring Delivering Ulipristal Acetate Combined With a Single or Repeated Levonorgestrel on Inhibition of Ovulation, Endometrial Changes and Bleeding Patterns in Normal Cycling Women	Phase 1/Phase 2
Completed	`NCT00805415` - Ovulation Inhibition of Two 4-phasic Oral Contraceptive Regimens	Phase 2
Completed	`NCT00915915` - Inhibition of Ovulation and Pharmacokinetics of Transdermal Ethinylestradiol (EE) and Gestodene (GSD)	Phase 2
Recruiting	`NCT02571543` - Can Ibuprofen Delay Ovulation in Natural Cycle-IVF?	Phase 2
Completed	`NCT01031355` - Bioequivalence Study: 3 mg Estradiol Valerate (EV) With and Without Levomefolate Calcium	Phase 1
Terminated	`NCT00729404` - Inhibition of Ovulation, Patch, Ethinylestradiol and Gestodene	Phase 2